( A and B ) Intracellular cAMP accumulation measured by enzymatic immunoassay in lysates from ( A ) caSMCs and ( B ) mouse and human caECs treated for 10 minutes with 100 nM each of GLP-1(2836), scrambled control, IPE, forskolin, or PBS control ( n = 3/treatment, each in triplicate)
Some people achieve meaningful results on lower doses, while others are unable to tolerate stronger tablets because of side effects
GLP-1s are given by injection and include such drugs as semaglutide, which has been used for more than 15 years to regular blood sugar in diabetes and is the active ingredient in the popular weight loss drugs Wegovy and Ozempic
A large 2026 analysis of over 9,000 patients found that people who stopped semaglutide or tirzepatide regained an average of nearly 2 pounds per month
It was carried out at 50 outpatient clinics in nine countries across Asia, Europe, and North America
This compound is not FDA-approved for clinical or therapeutic use and is not intended to diagnose, treat, cure, or prevent any disease or condition .